01943 663943

PolarisDX Chair side lateral flow blood test: cTnl Troponin

  • Brand: polaris
  • Availability: In Stock
  • SKU:
£540.00

Cardiac Troponin I (cTnI) Rapid Flow Test – Pack of 25 The Cardiac Troponin I (cTnI) Rapid Flow Test is a single-use capillary assay designed for use with the PolarisDX Igloo Pro device. Using a small finger-prick blood sample, it provides a quantitative cTnI value in minutes, helping you identify patients who may need urgent medical review for possible cardiac muscle injury. What the cTnI Test Measures Cardiac muscle injury: cTnI is a protein released into the blood when heart muscle cells are damaged. Support in assessing chest symptoms: Raised values can be seen in acute coronary syndromes and other...

Product Description

Cardiac Troponin I (cTnI) Rapid Flow Test – Pack of 25

The Cardiac Troponin I (cTnI) Rapid Flow Test is a single-use capillary assay designed for use with the PolarisDX Igloo Pro device. Using a small finger-prick blood sample, it provides a quantitative cTnI value in minutes, helping you identify patients who may need urgent medical review for possible cardiac muscle injury.

What the cTnI Test Measures

  • Cardiac muscle injury: cTnI is a protein released into the blood when heart muscle cells are damaged.
  • Support in assessing chest symptoms: Raised values can be seen in acute coronary syndromes and other causes of myocardial injury.
  • Background cardiac risk insight: Helps you decide when a patient’s symptoms and history warrant urgent medical assessment.
  • Objective reference point: Provides a numerical value that can be shared with emergency or primary care teams.

Benefits of cTnI Testing for Patients

  • Faster decision-making: A rapid result can help determine whether to seek urgent care without delay.
  • Clearer understanding of risk: Supports conversations about symptoms such as chest discomfort, shortness of breath, or unexplained fatigue.
  • Convenient finger-prick test: Avoids the need for immediate venous blood sampling on-site.
  • Improved communication with clinicians: Results can be shared in real time with GPs, NHS 111, or emergency departments.

Any patient with chest pain, shortness of breath, collapse, or other concerning symptoms should be advised to seek urgent medical attention, regardless of the test result.

When cTnI Testing May Be Considered

  • Patients reporting recent chest or upper body discomfort: Especially when symptoms are atypical or unclear.
  • High-risk individuals: Patients with a history of cardiovascular disease, diabetes, hypertension, or smoking.
  • Unwell patients in your chair: When a patient becomes acutely unwell during a dental or wellness appointment and you need extra information to guide escalation.
  • Follow-up after medical advice: When a healthcare professional has recommended troponin monitoring in appropriate settings.

Benefits for Your Clinic or Wellness Service

  • Enhanced patient safety: Adds an extra layer of clinical information when deciding whether to escalate care.
  • Clear documentation: Results are stored on the Igloo Pro device and can be downloaded or shared as needed.
  • Professional collaboration: Allows you to give objective data to GPs, urgent care, or emergency teams when referring a patient.
  • Added value to your service: Shows patients you take their overall health seriously, not just their presenting concern.

Each box contains 25 single-use Cardiac Troponin I (cTnI) Rapid Flow tests, ready for use with the PolarisDX Igloo Pro. This test is intended as a screening and decision-support tool. It does not replace hospital-based cardiac assessment or formal diagnosis by a GP, cardiologist, or emergency physician.

Tags: